pntg-20200630
000176640012/312020Q2false.50.50P5Y00017664002020-01-012020-06-30xbrli:shares00017664002020-08-11iso4217:USD00017664002020-06-3000017664002019-12-31iso4217:USDxbrli:shares00017664002020-04-012020-06-3000017664002019-04-012019-06-3000017664002019-01-012019-06-300001766400us-gaap:CommonStockMember2019-12-310001766400us-gaap:AdditionalPaidInCapitalMember2019-12-310001766400us-gaap:RetainedEarningsMember2019-12-310001766400us-gaap:TreasuryStockMember2019-12-310001766400us-gaap:RetainedEarningsMember2020-01-012020-03-3100017664002020-01-012020-03-310001766400us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001766400us-gaap:CommonStockMember2020-01-012020-03-310001766400us-gaap:CommonStockMember2020-03-310001766400us-gaap:AdditionalPaidInCapitalMember2020-03-310001766400us-gaap:RetainedEarningsMember2020-03-310001766400us-gaap:TreasuryStockMember2020-03-3100017664002020-03-310001766400us-gaap:RetainedEarningsMember2020-04-012020-06-300001766400us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001766400us-gaap:CommonStockMember2020-04-012020-06-300001766400us-gaap:TreasuryStockMember2020-04-012020-06-300001766400us-gaap:CommonStockMember2020-06-300001766400us-gaap:AdditionalPaidInCapitalMember2020-06-300001766400us-gaap:RetainedEarningsMember2020-06-300001766400us-gaap:TreasuryStockMember2020-06-300001766400us-gaap:CommonStockMember2018-12-310001766400us-gaap:AdditionalPaidInCapitalMember2018-12-310001766400us-gaap:RetainedEarningsMember2018-12-310001766400us-gaap:ParentMember2018-12-310001766400us-gaap:NoncontrollingInterestMember2018-12-3100017664002018-12-310001766400us-gaap:ParentMember2019-01-012019-03-310001766400us-gaap:NoncontrollingInterestMember2019-01-012019-03-3100017664002019-01-012019-03-310001766400us-gaap:CommonStockMember2019-03-310001766400us-gaap:AdditionalPaidInCapitalMember2019-03-310001766400us-gaap:RetainedEarningsMember2019-03-310001766400us-gaap:ParentMember2019-03-310001766400us-gaap:NoncontrollingInterestMember2019-03-3100017664002019-03-310001766400us-gaap:ParentMember2019-04-012019-06-300001766400us-gaap:NoncontrollingInterestMember2019-04-012019-06-300001766400us-gaap:CommonStockMember2019-06-300001766400us-gaap:AdditionalPaidInCapitalMember2019-06-300001766400us-gaap:RetainedEarningsMember2019-06-300001766400us-gaap:ParentMember2019-06-300001766400us-gaap:NoncontrollingInterestMember2019-06-3000017664002019-06-30pntg:agency0001766400pntg:HomeHealthAndHospiceServicesSegmentMember2020-06-30pntg:facility0001766400pntg:SeniorLivingServicesSegmentMember2020-06-30xbrli:pure00017664002019-10-010001766400us-gaap:CommonStockMember2019-10-012019-10-01pntg:property0001766400srt:AffiliatedEntityMemberpntg:SeniorLivingServicesSegmentMember2020-06-300001766400srt:MinimumMembersrt:AffiliatedEntityMemberpntg:SeniorLivingServicesSegmentMember2020-06-300001766400srt:MaximumMembersrt:AffiliatedEntityMemberpntg:SeniorLivingServicesSegmentMember2020-06-300001766400pntg:OperatingLeaseRentExpenseMembersrt:AffiliatedEntityMember2020-04-012020-06-300001766400pntg:OperatingLeaseRentExpenseMembersrt:AffiliatedEntityMember2020-01-012020-06-300001766400pntg:OperatingLeaseRentExpenseMembersrt:AffiliatedEntityMember2019-04-012019-06-300001766400pntg:OperatingLeaseRentExpenseMembersrt:AffiliatedEntityMember2019-01-012019-06-300001766400pntg:TransitionServicesAgreementMembersrt:AffiliatedEntityMember2020-04-012020-06-300001766400srt:AffiliatedEntityMember2020-01-012020-06-300001766400pntg:TransitionServicesAgreementMembersrt:AffiliatedEntityMember2019-04-012019-06-300001766400srt:AffiliatedEntityMember2019-01-012019-06-300001766400pntg:TransitionServicesAgreementMembersrt:AffiliatedEntityMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareAndMedicaidMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareAndMedicaidMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareAndMedicaidMember2019-04-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareAndMedicaidMember2019-01-012019-06-300001766400pntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMemberpntg:HomeHealthSubsegmentMember2020-04-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMember2020-04-012020-06-300001766400pntg:MedicareMemberpntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400pntg:MedicareMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareMember2020-04-012020-06-300001766400pntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2020-04-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMember2020-04-012020-06-300001766400pntg:MedicaidMemberpntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400pntg:MedicaidMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:MedicaidMemberus-gaap:RevenueFromContractWithCustomerMember2020-04-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMemberpntg:HomeHealthSubsegmentMember2020-04-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMember2020-04-012020-06-300001766400pntg:MedicareAndMedicaidMemberpntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400pntg:MedicareAndMedicaidMember2020-04-012020-06-300001766400pntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2020-04-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMember2020-04-012020-06-300001766400pntg:ManagedCareMemberpntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400pntg:ManagedCareMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:ManagedCareMemberus-gaap:RevenueFromContractWithCustomerMember2020-04-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMemberpntg:HomeHealthSubsegmentMember2020-04-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMember2020-04-012020-06-300001766400pntg:PrivateAndOtherMemberpntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400pntg:PrivateAndOtherMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:PrivateAndOtherMember2020-04-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2020-04-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMember2020-04-012020-06-300001766400pntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-04-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMemberpntg:HomeHealthSubsegmentMember2019-04-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMember2019-04-012019-06-300001766400pntg:MedicareMemberpntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400pntg:MedicareMember2019-04-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareMember2019-04-012019-06-300001766400pntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2019-04-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMember2019-04-012019-06-300001766400pntg:MedicaidMemberpntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400pntg:MedicaidMember2019-04-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:MedicaidMemberus-gaap:RevenueFromContractWithCustomerMember2019-04-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMemberpntg:HomeHealthSubsegmentMember2019-04-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMember2019-04-012019-06-300001766400pntg:MedicareAndMedicaidMemberpntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400pntg:MedicareAndMedicaidMember2019-04-012019-06-300001766400pntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2019-04-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMember2019-04-012019-06-300001766400pntg:ManagedCareMemberpntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400pntg:ManagedCareMember2019-04-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:ManagedCareMemberus-gaap:RevenueFromContractWithCustomerMember2019-04-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMemberpntg:HomeHealthSubsegmentMember2019-04-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMember2019-04-012019-06-300001766400pntg:PrivateAndOtherMemberpntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400pntg:PrivateAndOtherMember2019-04-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:PrivateAndOtherMember2019-04-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2019-04-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMember2019-04-012019-06-300001766400pntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2019-04-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMemberpntg:HomeHealthSubsegmentMember2020-01-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMember2020-01-012020-06-300001766400pntg:MedicareMemberpntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400pntg:MedicareMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareMember2020-01-012020-06-300001766400pntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2020-01-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMember2020-01-012020-06-300001766400pntg:MedicaidMemberpntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400pntg:MedicaidMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:MedicaidMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMemberpntg:HomeHealthSubsegmentMember2020-01-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMember2020-01-012020-06-300001766400pntg:MedicareAndMedicaidMemberpntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400pntg:MedicareAndMedicaidMember2020-01-012020-06-300001766400pntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2020-01-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMember2020-01-012020-06-300001766400pntg:ManagedCareMemberpntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400pntg:ManagedCareMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:ManagedCareMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMemberpntg:HomeHealthSubsegmentMember2020-01-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMember2020-01-012020-06-300001766400pntg:PrivateAndOtherMemberpntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400pntg:PrivateAndOtherMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:PrivateAndOtherMember2020-01-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2020-01-012020-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMember2020-01-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMemberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareMember2019-01-012019-06-300001766400pntg:MedicareMemberpntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400pntg:MedicareMember2019-01-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:MedicareMember2019-01-012019-06-300001766400pntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:MedicaidMemberpntg:HomeHealthAndHospiceServicesSegmentMember2019-01-012019-06-300001766400pntg:MedicaidMemberpntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400pntg:MedicaidMember2019-01-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:MedicaidMemberus-gaap:RevenueFromContractWithCustomerMember2019-01-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMemberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:MedicareAndMedicaidMember2019-01-012019-06-300001766400pntg:MedicareAndMedicaidMemberpntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400pntg:MedicareAndMedicaidMember2019-01-012019-06-300001766400pntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:ManagedCareMemberpntg:HomeHealthAndHospiceServicesSegmentMember2019-01-012019-06-300001766400pntg:ManagedCareMemberpntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400pntg:ManagedCareMember2019-01-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberpntg:ManagedCareMemberus-gaap:RevenueFromContractWithCustomerMember2019-01-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMemberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:PrivateAndOtherMember2019-01-012019-06-300001766400pntg:PrivateAndOtherMemberpntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400pntg:PrivateAndOtherMember2019-01-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMemberpntg:PrivateAndOtherMember2019-01-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMember2019-01-012019-06-300001766400pntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2019-01-012019-06-300001766400pntg:MedicareMember2020-06-300001766400pntg:MedicareMember2019-12-310001766400pntg:MedicaidMember2020-06-300001766400pntg:MedicaidMember2019-12-310001766400pntg:ManagedCareMember2020-06-300001766400pntg:ManagedCareMember2019-12-310001766400pntg:PrivateAndOtherMember2020-06-300001766400pntg:PrivateAndOtherMember2019-12-310001766400pntg:HomeHealthAndHospiceServicesSegmentMemberus-gaap:OperatingSegmentsMember2020-04-012020-06-300001766400us-gaap:OperatingSegmentsMemberpntg:SeniorLivingServicesSegmentMember2020-04-012020-06-300001766400us-gaap:CorporateNonSegmentMember2020-04-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberus-gaap:OperatingSegmentsMember2019-04-012019-06-300001766400us-gaap:OperatingSegmentsMemberpntg:SeniorLivingServicesSegmentMember2019-04-012019-06-300001766400us-gaap:CorporateNonSegmentMember2019-04-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-06-300001766400us-gaap:OperatingSegmentsMemberpntg:SeniorLivingServicesSegmentMember2020-01-012020-06-300001766400us-gaap:CorporateNonSegmentMember2020-01-012020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-06-300001766400us-gaap:OperatingSegmentsMemberpntg:SeniorLivingServicesSegmentMember2019-01-012019-06-300001766400us-gaap:CorporateNonSegmentMember2019-01-012019-06-3000017664002020-05-012020-06-30pntg:home_health_agencypntg:hospice_agencypntg:stand-alone_senior_living_operationpntg:senior_living_unit0001766400pntg:BusinessAcquisitions2020Member2020-01-012020-06-300001766400pntg:BusinessAcquisitions2020Member2020-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:BusinessAcquisitions2019Memberpntg:HomeHealthSubsegmentMember2019-01-012019-06-300001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberpntg:BusinessAcquisitions2019Member2019-01-012019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberpntg:BusinessAcquisitions2019Member2019-01-012019-06-300001766400pntg:SeniorLivingServicesSegmentMemberpntg:BusinessAcquisitions2019Member2019-01-012019-06-300001766400pntg:SeniorLivingServicesSegmentMember2019-06-300001766400pntg:BusinessAcquisitions2019Member2019-01-012019-06-300001766400pntg:BusinessAcquisitions2019Member2019-06-300001766400pntg:HomeHealthAndHospiceServicesSegmentMemberus-gaap:SubsequentEventMemberpntg:HomeHealthSubsegmentMember2020-07-012020-07-010001766400pntg:HospiceSubsegmentMemberpntg:HomeHealthAndHospiceServicesSegmentMemberus-gaap:SubsequentEventMember2020-07-012020-07-010001766400pntg:BusinessAcquisitions2020Memberus-gaap:SubsequentEventMember2020-07-012020-07-010001766400us-gaap:LeaseholdImprovementsMember2020-06-300001766400us-gaap:LeaseholdImprovementsMember2019-12-310001766400us-gaap:EquipmentMember2020-06-300001766400us-gaap:EquipmentMember2019-12-310001766400us-gaap:FurnitureAndFixturesMember2020-06-300001766400us-gaap:FurnitureAndFixturesMember2019-12-310001766400pntg:HomeHealthAndHospiceServicesSegmentMember2019-12-310001766400pntg:SeniorLivingServicesSegmentMember2019-12-310001766400pntg:HomeHealthAndHospiceServicesSegmentMember2020-01-012020-06-300001766400us-gaap:TradeNamesMember2020-06-300001766400us-gaap:TradeNamesMember2019-12-310001766400us-gaap:LicensingAgreementsMember2020-06-300001766400us-gaap:LicensingAgreementsMember2019-12-310001766400us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-06-300001766400us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2019-12-310001766400us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2019-10-010001766400srt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-01-012020-06-300001766400srt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-01-012020-06-300001766400srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMember2020-01-012020-06-300001766400srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMember2020-01-012020-06-300001766400us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2019-10-012019-10-010001766400us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMember2020-06-300001766400us-gaap:EmployeeStockOptionMember2020-04-012020-06-300001766400us-gaap:EmployeeStockOptionMember2019-04-012019-06-300001766400us-gaap:EmployeeStockOptionMember2020-01-012020-06-300001766400us-gaap:EmployeeStockOptionMember2019-01-012019-06-300001766400us-gaap:RestrictedStockMember2020-04-012020-06-300001766400us-gaap:RestrictedStockMember2019-04-012019-06-300001766400us-gaap:RestrictedStockMember2020-01-012020-06-300001766400us-gaap:RestrictedStockMember2019-01-012019-06-300001766400srt:DirectorMemberus-gaap:RestrictedStockMember2020-04-012020-06-300001766400srt:DirectorMemberus-gaap:RestrictedStockMember2019-04-012019-06-300001766400srt:DirectorMemberus-gaap:RestrictedStockMember2020-01-012020-06-300001766400srt:DirectorMemberus-gaap:RestrictedStockMember2019-01-012019-06-300001766400us-gaap:EmployeeStockOptionMemberpntg:TheEnsignPlansMember2020-06-300001766400us-gaap:EmployeeStockOptionMemberpntg:TheEnsignPlansMember2020-01-012020-06-300001766400us-gaap:RestrictedStockMemberpntg:TheEnsignPlansMember2020-06-300001766400us-gaap:RestrictedStockMemberpntg:TheEnsignPlansMember2020-01-012020-06-300001766400pntg:TheEnsignPlansMember2020-06-300001766400pntg:GrantYear2019Memberpntg:TheEnsignPlansMember2020-01-012020-06-300001766400pntg:GrantYear2019Memberus-gaap:EmployeeStockOptionMemberpntg:TheEnsignPlansMember2020-01-012020-06-300001766400pntg:TheEnsignPlansMember2019-12-310001766400pntg:TheEnsignPlansMember2020-01-012020-06-300001766400pntg:TheEnsignPlansMember2019-10-022019-12-310001766400us-gaap:RestrictedStockMemberpntg:TheEnsignPlansMember2019-12-310001766400srt:MinimumMemberpntg:SeniorLivingServicesSegmentMember2020-06-300001766400srt:MaximumMemberpntg:SeniorLivingServicesSegmentMember2020-06-30pntg:arrangement0001766400us-gaap:CostOfSalesMemberpntg:FacilityMember2020-04-012020-06-300001766400us-gaap:CostOfSalesMemberpntg:FacilityMember2019-04-012019-06-300001766400us-gaap:CostOfSalesMemberpntg:FacilityMember2020-01-012020-06-300001766400us-gaap:CostOfSalesMemberpntg:FacilityMember2019-01-012019-06-300001766400us-gaap:CostOfSalesMembersrt:OfficeBuildingMember2020-04-012020-06-300001766400us-gaap:CostOfSalesMembersrt:OfficeBuildingMember2019-04-012019-06-300001766400us-gaap:CostOfSalesMembersrt:OfficeBuildingMember2020-01-012020-06-300001766400us-gaap:CostOfSalesMembersrt:OfficeBuildingMember2019-01-012019-06-300001766400us-gaap:CostOfSalesMember2020-04-012020-06-300001766400us-gaap:CostOfSalesMember2019-04-012019-06-300001766400us-gaap:CostOfSalesMember2020-01-012020-06-300001766400us-gaap:CostOfSalesMember2019-01-012019-06-300001766400us-gaap:GeneralAndAdministrativeExpenseMember2020-04-012020-06-300001766400us-gaap:GeneralAndAdministrativeExpenseMember2019-04-012019-06-300001766400us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-06-300001766400us-gaap:GeneralAndAdministrativeExpenseMember2019-01-012019-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberpntg:MedicareAndMedicaidMember2020-04-012020-06-300001766400us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberpntg:MedicareAndMedicaidMember2020-01-012020-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended June 30, 2020.
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
        For the transition period from                      to                     .
Commission file number: 001-38900
__________________________
THE PENNANT GROUP, INC.

(Exact Name of Registrant as Specified in Its Charter)
Delaware
83-3349931
(State or Other Jurisdiction of(I.R.S. Employer
Incorporation or Organization)Identification No.)
1675 East Riverside Drive, Suite 150, Eagle, ID 83616
(Address of Principal Executive Offices and Zip Code)
(208) 506-6100
(Registrant’s Telephone Number, Including Area Code)
_____________________________
Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per sharePNTGNasdaq Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting companyEmerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
As of August 11, 2020, 27,980,650 shares of the registrant’s common stock were outstanding.




THE PENNANT GROUP, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2020
TABLE OF CONTENTS




PART I. FINANCIAL INFORMATION
Item I. Financial Statements
THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS
(unaudited, in thousands, except par value)

June 30, 2020December 31, 2019
Assets
Current assets:
Cash $12,129  $402  
Accounts receivable—less allowance for doubtful accounts of $516 and $677, respectively
33,858  32,183  
Prepaid expenses and other current assets6,443  6,098  
Total current assets52,430  38,683  
Property and equipment, net19,025  14,644  
Right-of-use assets311,821  316,328  
Escrow deposits1,639  1,400  
Restricted and other assets2,293  1,955  
Intangible assets, net38  45  
Goodwill45,372  41,233  
Other indefinite-lived intangibles36,628  33,462  
Total assets$469,246  $447,750  
Liabilities and equity
Current liabilities:
Accounts payable$7,224  $8,653  
Accrued wages and related liabilities18,278  16,343  
Lease liabilities—current13,369  12,285  
Other accrued liabilities41,590  13,911  
Total current liabilities80,461  51,192  
Long-term lease liabilities—less current portion300,621  304,044  
Other long-term liabilities5,021  2,877  
Long-term debt, net642  18,526  
Total liabilities386,745  376,639  
Commitments and contingencies
Equity:
Common stock, $0.001 par value; 100,000 shares authorized; 28,514 and 27,968, shares issued and outstanding at June 30, 2020, respectively, and 28,435 and 27,853 shares issued and outstanding at December 31, 2019, respectively.
28  28  
Additional paid-in capital79,012  74,882  
Retained Earnings/ (Accumulated Deficit)3,518  (3,799) 
Treasury Stock, at cost (57)   
Total equity82,501  71,111  
Total liabilities and equity$469,246  $447,750  
See accompanying notes to condensed consolidated and combined financial statements.

1


tzsdTHE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF INCOME
(unaudited, in thousands, except for per-share amounts)


Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Revenue$92,740  $82,734  $184,589  $160,641  
Expense
Cost of services68,159  63,038  138,348  121,767  
Rent—cost of services9,767  8,533  19,473  16,830  
General and administrative expense7,538  6,889  14,199  15,133  
Depreciation and amortization1,201  962  2,222  1,772  
Total expenses86,665  79,422  174,242  155,502  
Income from operations6,075  3,312  10,347  5,139  
Other income (expense):
Interest expense, net(301)   (704)   
Income before provision for income taxes5,774  3,312  9,643  5,139  
Provision/ (benefit) for income taxes1,437  (375) 2,326  (32) 
Net income4,337  3,687  7,317  5,171  
Less: net income attributable to noncontrolling interest  200    350  
Net income and other comprehensive income attributable to The Pennant Group, Inc. $4,337  $3,487  $7,317  $4,821  
Earnings per share:
Basic$0.16  $0.13  $0.26  $0.19  
Diluted$0.15  $0.13  $0.25  $0.19  
Weighted average common shares outstanding:
Basic27,952  27,834  27,922  27,834  
Diluted29,662  27,834  29,780  27,834  
See accompanying notes to condensed consolidated and combined financial statements.

2


THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY
AND NET PARENT INVESTMENT
(unaudited, in thousands)
Common StockAdditional Paid-In CapitalRetained Earnings/ (Accumulated Deficit)Treasury Stock
SharesAmountSharesAmountTotal
Balance at December 31, 201928,435  $28  $74,882  $(3,799)   $  $71,111  
Net income attributable to The Pennant Group, Inc.—  —  —  2,980  —  —  2,980  
Stock-based compensation —  —  1,956  —  —  —  1,956  
Issuance of common stock from the exercise of stock options38  —  138  —  —  —  138  
Issuance/ (cancellation) of restricted stock3  —  —  —  —  —  —  
Balance at March 31, 202028,476  $28  $76,976  $(819)   $  $76,185  
Net income attributable to The Pennant Group, Inc.—  —  —  4,337  —  —  4,337  
Stock-based compensation—  —  1,959  —  —  —  1,959  
Issuance of common stock from the exercise of stock options20  —  77  —  —  —  77  
Issuance/ (cancellation) of restricted stock20  —  —  —  —  —  —  
Shares of common stock used to satisfy tax withholding(2) —  —  —  2  (57) (57) 
Balance at June 30, 202028,514  $28  $79,012  $3,518  2  $(57) $82,501  

Common StockAdditional Paid-In CapitalNon-Controlling Interest
SharesAmountRetained EarningsNet Parent InvestmentTotal
Balance at December 31, 2018  $  $  $  $55,856  $9,432  $65,288  
Noncontrolling interest attributable to subsidiary equity plan—  —  —  —  (317) 658  341  
Net income attributable to noncontrolling interest—  —  —  —  —  150  150  
Net transfer from parent—  —  —  —  4,411  —  4,411  
Net income attributable to The Pennant Group, Inc. —  —  —  —  1,334  —  1,334  
Balance at March 31, 2019  $  $  $  $61,284  $10,240  $71,524  
Noncontrolling interest attributable to subsidiary equity plan—  —  —  —  (2,497) 2,733  236  
Net income attributable to noncontrolling interest—  —  —  —  —  200  200  
Net transfer from parent—  —  —  —  11,041  —  11,041  
Net income attributable to The Pennant Group, Inc.—  —  —  —  3,487  —  3,487  
Balance at June 30, 2019  $  $  $  $73,315  $13,173  $86,488  

See accompanying notes to condensed consolidated and combined financial statements.
3


THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS
(unaudited, in thousands)
Six Months Ended June 30,
20202019
Cash flows from operating activities:
Net income$7,317  $5,171  
Adjustments to reconcile net income to net cash provided by/ (used in) operating activities:
Depreciation and amortization2,222  1,772  
Amortization of deferred financing fees162    
Provision for doubtful accounts282  460  
Share-based compensation3,915  1,127  
Change in operating assets and liabilities:
Accounts receivable(2,077) (3,695) 
Prepaid expenses and other assets(232) (1,110) 
Operating lease obligations2,168  294  
Accounts payable(2,019) 162  
Accrued wages and related liabilities(937) (328) 
Other accrued liabilities4,600  150  
Contract Liabilities (CARES Act advance payments)27,997    
Net cash provided by operating activities43,398  4,003  
Cash flows from investing activities:
Purchase of property and equipment(5,963) (3,641) 
Cash payments for business acquisitions, net of escrow(6,868) (14,759) 
Cash payments for asset acquisitions  (20) 
Escrow deposits(639)   
Restricted and other assets(333) (147) 
Net cash used in investing activities(13,803) (18,567) 
Cash flows from financing activities:
Proceeds from sale of subsidiary shares  2,293  
Repurchase of subsidiary shares   (2,293) 
Net investment from parent  14,566  
Proceeds from revolver agreement26,500    
Payments on revolver agreement(44,500)   
Repurchase of shares of common stock to satisfy tax witholding obligations(57)   
Payments for deferred financing costs(26)   
Issuance of common stock upon the exercise of options215    
Net cash (used)/ provided by financing activities(17,868) 14,566  
Net increase in cash 11,727  2  
Cash beginning of period402  41  
Cash end of period$12,129  $43  
See accompanying notes to condensed consolidated and combined financial statements.

4


THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - (Continued)
(unaudited, in thousands)
Six Months Ended June 30,
20202019
Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest$619  $  
Income taxes$2,430  $  
Lease liabilities$18,462  $16,721  
Right-of-use assets obtained in exchange for new operating lease obligations$3,437  $4,198  
Net non-cash adjustment to right-of-use assets and lease liabilities from lease modifications$441  $  
Non-cash investing activity:
Capital expenditures$1,035  $600  
See accompanying notes to condensed consolidated and combined financial statements.
5



THE PENNANT GROUP INC.
NOTES TO THE CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
(In thousands, except per share data )
1. DESCRIPTION OF BUSINESS

The Pennant Group, Inc. (herein referred to as “Pennant,” the “Company,” “it,” or “its”), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of June 30, 2020, the Company’s subsidiaries operated 67 home health, hospice and home care agencies and 54 senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming.

On October 1, 2019, The Ensign Group, Inc. (NASDAQ: ENSG) (“Ensign” or the “Parent”) completed the separation of Pennant (the “Spin-Off”). To accomplish the Spin-Off, Ensign contributed all of its home health and hospice and substantially all of its senior living businesses into Pennant and distributed to Ensign’s stockholders all of the outstanding shares of Pennant common stock. Each Ensign stockholder received a distribution of one share of Pennant’s common stock for every two shares of Ensign’s common stock, plus cash in lieu of fractional shares. Additionally, the noncontrolling interest was converted into shares of Pennant at the established conversion ratio. As a result of the Spin-Off on October 1, 2019, Pennant began trading as an independent company on the NASDAQ under the symbol “PNTG.”
Certain of the Company’s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships.
Each of the Company’s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated “Company” and “its” assets and activities is not meant to imply, nor should it be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries, are operated by Pennant.

2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation - The accompanying unaudited condensed consolidated and combined financial statements of the Company (the “Interim Financial Statements”) reflect the Company’s financial position, results of operations and cash flows of the business. The Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the regulations of the Securities and Exchange Commission (“SEC”). Management believes that the Interim Financial Statements reflect, in all material respects, all adjustments which are of a normal and recurring nature necessary to present fairly the Company’s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP. The results reported in these financial statements are not necessarily indicative of results that may be expected for the entire year.

The Condensed Consolidated and Combined Balance Sheet as of December 31, 2019 is derived from the Company’s annual audited Consolidated and Combined Financial Statements for the fiscal year ended December 31, 2019 which should be read in conjunction with these Interim Financial Statements. Certain information in the accompanying footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with GAAP.

All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. The condensed consolidated and combined statements of income reflect income that is attributable to the Company and the noncontrolling interest.

The Company consists of various limited liability companies and corporations established to operate home health, hospice, home care, and senior living operations. The Interim Financial Statements include the accounts of all entities controlled by the Company through its ownership of a majority voting interest. Revenue was derived from transactional information specific to the Company’s services provided. The costs in the condensed consolidated and combined statements of income reflect direct costs.

Estimates and Assumptions - The preparation of the Interim Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and
6

Table of Contents
THE PENNANT GROUP, INC.
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)

expenses during the reporting periods. The most significant estimates in the Interim Financial Statements relate to revenue, cost allocations, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, and income taxes. Actual results could differ from those estimates.

Prior to Spin Off - Prior to the Spin-Off, the combined financial statements were prepared on a stand-alone basis and derived from the consolidated financial statements and accounting records of Ensign. The Interim Financial Statements include allocations of costs for certain shared services provided to the Company by Ensign subsidiaries prior to the Spin-Off on October 1, 2019. Such allocations include, but are not limited to, executive management, accounting, human resources, information technology, compliance, legal, payroll, insurance, tax, treasury, and other general and administrative items. These costs were allocated to the Company on a basis of revenue, location, employee count, or other measures. These cost allocations are reflected within general and administrative expense in the condensed consolidated and combined statements of income, including for share-based compensation expenses disclosed in Note 12, Options and Awards. The amount of general and administrative costs allocated for the three and six months ended June 30, 2019, inclusive of share-based compensation expense, was $6,889 and $15,133, respectively. Management believes the basis on which the expenses were allocated to be a reasonable reflection of the services provided to the Company during the periods.

Ensign’s external debt and related interest expense were not allocated to the Company for any of the periods presented prior to the Spin-Off as no portion of Ensign’s borrowings were assumed by the Company as part of the Spin-Off.

Prior to the date of the Spin-off, the Company’s operations have been included in Ensign’s U.S. federal and state income tax returns and all income taxes have been paid by subsidiaries of Ensign. Income tax expense and other income tax related information contained in these Interim Financial Statements for the periods prior to the Spin-Off were presented using a separate tax return approach.

Prior to the Spin-Off, the Company presented the noncontrolling interest and the amount of consolidated net income attributable to the Company in the Interim Financial Statements. The carrying amount of the noncontrolling interest was adjusted by an allocation of subsidiary earnings based on ownership interest prior to the Spin-Off. The noncontrolling subsidiary interest included in the Interim Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off. For all prior periods presented prior to the Spin-Off, the earnings per share included on the accompanying Condensed Consolidated and Combined Statements of Income was calculated based on the 27,834 shares of Pennant common stock distributed on October 1, 2019 in conjunction with the Spin-Off, including shares related to the conversion of the noncontrolling interest.

Recent Accounting Standards Adopted by the Company

FASB Accounting Standards Update, or ASU, ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” or ASU 2020-4 - In March 2020, the FASB concluded its reference rate reform project and issued this ASU. The amendments in this ASU provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The optional expedients and exceptions are available for all entities as of March 12, 2020, through December 31, 2022. The Company has adopted ASU 2020-04, effective March 12, 2020. The impact of this ASU will be determined based on terms of any future contract modification related to a change in reference rate, including future modifications to the Company’s Revolving Credit Facility described in further detail in Note 11, Debt.

FASB ASU, 2018-13 “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” or ASU 2018-13 - In August 2018, the FASB issued amended guidance to simplify fair value measurement disclosure requirements. The new provisions eliminate the requirements to disclose (1) transfers between Level 1 and Level 2 of the fair value hierarchy, (2) policies related to valuation processes and the timing of transfers between levels of the fair value hierarchy, and (3) net asset value disclosure of estimates of timing of future liquidity events. The FASB also modified disclosure requirements of Level 3 fair value measurements. The Company adopted ASU 2018-13 as of January 1, 2020. There was no material impact to the Company’s financial statements or disclosures.

FASB ASU, 2017-04 “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” or ASU 2017-04 - In January 2017, the FASB issued amended authoritative guidance to simplify and reduce the cost and complexity of the goodwill impairment test. The new guidance eliminates “Step 2” from the traditional two-step goodwill impairment test and redefines the concept of impairment from a measure of loss when comparing the implied fair value of goodwill to its carrying amount, to a measure comparing the fair value of a reporting unit with its carrying amount. The FASB
7

Table of Contents
THE PENNANT GROUP, INC.
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)

also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment or “Step 2” of the goodwill impairment test. The new guidance does not amend the optional qualitative assessment of goodwill impairment. The Company adopted ASU 2017-04 as of January 1, 2020. There was no material impact to the Company’s financial statements or disclosures.

FASB ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” or ASU 2016-13 - In June 2016, the FASB issued ASU 2016-13, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The Company adopted ASU 2016-13 as of January 1, 2020. There was no material impact to the Company’s financial statements or related disclosures.

3. RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT
The Interim Financial Statements include a combination of stand-alone and combined business functions between Ensign and the Company’s subsidiaries prior to the Spin-Off. The Company leases 31 of its senior living communities from subsidiaries of Ensign, each of the leases have a term of between 14 and 16 years from the lease commencement date. The total amount of rent expense included in Rent - cost of services paid to subsidiaries of Ensign was $3,071 and $6,172 for the three and six months ended June 30, 2020, respectively, and $2,774 and $5,467, for the three and six months ended June 30, 2019, respectively.

The Company’s subsidiaries received services from Ensign’s subsidiaries. Services included in cost of services were $1,166 and $2,188, for the three and six months ended June 30, 2020 and $780 and $1,495, for the three and six months ended June 30, 2019, respectively.

Transactions that occurred, prior to the Spin-Off, between subsidiaries of the Company and subsidiaries of Ensign were considered to be effectively settled at the time the transaction was recorded. The net effect of these transactions, including the cash management, is included in the Condensed Consolidated and Combined Statements of Cash Flows as “Net investment from/(to) Parent”.

Other related party activity with Ensign
On October 1, 2019, in connection with the Spin-Off, Pennant entered into several agreements with Ensign that set forth the principal actions taken or to be taken in connection with the Spin-Off and govern the relationship of the parties following the Spin-Off. The Company has incurred $1,525 and $2,861 in costs, net of the Company’s payroll reimbursement, related primarily to administrative support under the Transitions Services Agreement for the three and six months ended June 30, 2020, respectively.


4. COMPUTATION OF NET INCOME PER COMMON SHARE
Basic and diluted net income per share are computed by dividing net income by the weighted average number of outstanding common shares during the period. In the basic and diluted earnings per share calculations, net income is equal to net income attributable to The Pennant Group, Inc. adjusted to include net income attributable to noncontrolling interest. Net income attributable to the noncontrolling interest has been included in the numerator for all periods as the non-controlling subsidiary interest included in the Interim Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off. The total number of common shares distributed on October 1, 2019 of 27,834 is being utilized for the calculation of basic and diluted earnings per share for all prior periods, as no common stock was outstanding prior to the date of the Spin-Off.

8

Table of Contents
THE PENNANT GROUP, INC.
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)

The following table sets forth the computation of basic and diluted net income per share for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
 2020201920202019
Numerator: 
Net income attributable to The Pennant Group, Inc.$4,337  $3,487  $7,317  $4,821  
Add: net income attributable to noncontrolling interests  200    350  
Net Income$4,337  $3,687  $7,317  $5,171  
Denominator:
Weighted average shares outstanding for basic net income per share27,952  27,834  27,922  27,834  
Plus: assumed incremental shares from exercise of options and assumed conversion or vesting of restricted stock(a)
1,710    1,858    
Adjusted weighted average common shares outstanding for diluted income per share29,662  27,834  29,780  27,834  
Earnings Per Share:
Basic net income per common share$0.16  $0.13  $0.26  $0.19  
Diluted net income per common share$0.15  $0.13  $0.25  $0.19  

(a)
The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such options’ exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were 240 and 102 for the three and six months ended June 30, 2020, respectively.


5. REVENUE AND ACCOUNTS RECEIVABLE
Revenues are recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private, Medicare Advantage and Medicare replacement plans), in exchange for providing patient care. The healthcare services in home health and hospice patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct within the context of the contract. Additionally, there may be ancillary services which are not included in the rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.

Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company’s estimates, the Company adjusts these estimates, which would affect net service revenue in the period such variances become known.

Revenue from the Medicare and Medicaid programs accounted for 59.4% and 58.7%, for the three and six months ended June 30, 2020, respectively, and 54.9% and 54.1%, of the Company’s revenue for the three and six months ended June 30, 2019, respectively. The Company records revenue from these governmental and managed care programs as services are performed at their expected net realizable amounts under these programs. The Company’s revenue from governmental and managed care programs is subject to audit and retroactive adjustment by governmental and third-party agencies. Consistent with healthcare industry accounting practices, any changes to these governmental revenue estimates are recorded in the period the change or adjustment becomes known based on final settlement.

9

Table of Contents
THE PENNANT GROUP, INC.
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)
During the quarter the Company received CARES Act Provider Relief Fund (the “PRF”) payments in the amount of $9,858, and during the quarter the Company returned the full amount of payments received.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with its patients by reportable operating segments and payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

The Company’s service specific revenue recognition policies are as follows:

Home Health Revenue

Medicare Revenue

For Medicare episodes that began after January 1, 2020, net service revenue is recognized in accordance with the Patient Driven Groupings Model (“PDGM”). This new reimbursement structure involves case mix calculation methodology refinements, changes to low-utilization payment adjustment (“LUPA”) thresholds, the elimination of therapy thresholds, a change to the unit of payment from a 60-day episode to a 30-day payment period, and reduction of requests for anticipated payments (“RAPs”) to 20% of the estimated payment for a patient’s initial or subsequent period of care up-front (after the initial assessment is completed and upon initial billing). The RAPs will be completely phased out effective January 1, 2021. Under PDGM, Medicare provides agencies with payments for each 30-day payment period provided to beneficiaries. If a beneficiary is still eligible for care after the end of the first 30-day payment period, a second 30-day payment period can begin. There are no limits to the number of periods of care a beneficiary who remains eligible for the home health benefit can receive. While payment for each 30-day payment period is adjusted to reflect the beneficiary’s health condition and needs, a special outlier provision exists to ensure appropriate payment for those beneficiaries that have the most expensive care needs. The payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a LUPA if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day payment period (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments.

For all episodes that began prior to January 1, 2020, net service revenue was recorded under the Medicare prospective payment system based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) an outlier payment if the patient’s care was unusually costly; (b) a LUPA if the number of visits was fewer than five; (c) a partial payment if the patient transferred to another provider or transferred from another provider before completing the episode; (d) a payment adjustment based upon the level of covered therapy services; (e) the number of episodes of care provided to a patient, regardless of whether the same home health provider provided care for the entire series of episodes; (f) changes in the base episode payments established by the Medicare program; (g) adjustments to the base episode payments for case mix and geographic wages; and (h) recoveries of overpayments.

The Company adjusts Medicare revenue on completed episodes to reflect differences between estimated and actual payment amounts, an inability to obtain appropriate billing documentation and other reasons unrelated to credit risk. Therefore, the Company believes that its reported net service revenue and patient accounts receivable will be the net amounts to be realized from Medicare for services rendered.

In addition to revenue recognized on completed episodes and periods, the Company also recognizes a portion of revenue associated with episodes and periods in progress. Episodes in progress are 30-day payment periods, if the episode started after January 1, 2020, or 60-day episodes of care, if the episode started prior to January 1, 2020, that begin during the reporting period but were not completed as of the end of the period. As such, the Company estimates revenue and recognizes it on a daily basis. The primary factors underlying this estimate are the number of episodes in progress at the end of the reporting period, expected Medicare revenue per period of care or episode of care and the Company’s estimate of the average percentage complete based on the scheduled end of period and end of episode dates.
10

Table of Contents
THE PENNANT GROUP, INC.
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)

Non-Medicare Revenue

Episodic Based Revenue - The Company recognizes revenue in a similar manner as it recognizes Medicare revenue for episodic-based rates that are paid by other insurance carriers, including Medicare Advantage programs. These rates can vary based upon the negotiated terms.

Non-episodic Based Revenue - Revenue is recognized on an accrual basis based upon the date of service at amounts equal to its established or estimated per visit rates, as applicable.

Hospice Revenue

Revenue is recognized on an accrual basis based upon the date of service at amounts equal to the estimated payment rates. The estimated payment rates are calculated as daily rates for each of the levels of care the Company delivers. Revenue is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to the payor and other reasons unrelated to credit risk. Additionally, as Medicare hospice revenue is subject to an inpatient cap and an overall payment cap, the Company monitors its provider numbers and estimates amounts due back to Medicare if a cap has been exceeded. The Company records these adjustments as a reduction to revenue and an increase to other accrued liabilities.

Senior Living Revenue

The Company has elected the lessor practical expedient within ASC Topic 842, Leases (“ASC 842”) and therefore recognizes, measures, presents, and discloses the revenue for services rendered under the Company’s senior living residency agreements based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the services included under the Company’s senior living residency agreements each have the same timing and pattern of transfer. The Company recognizes revenue under ASC 606 for its senior residency agreements, for which it has determined that the non-lease components of such residency agreements are the predominant component of each such contract.

The Company’s senior living revenue consists of fees for basic housing and assisted living care. Accordingly, the Company records revenue when services are rendered on the date services are provided at amounts billable to individual residents. Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.

Revenue by payor for the three and six months ended June 30, 2020 and 2019, is summarized in the following tables:

Three Months Ended June 30, 2020
Home Health and Hospice Services
Home Health ServicesHospice ServicesSenior Living ServicesTotal RevenueRevenue %
Medicare$11,808  $28,550  $  $40,358  43.5 %
Medicaid1,963  3,637  9,155  14,755  15.9  
Subtotal13,771  32,187  9,155  55,113  59.4  
Managed care6,846  397    7,243  7.8  
Private and other(a)
4,744  39  25,601  30,384  32.8  
Total revenue$25,361  $32,623  $34,756  $92,740  100.0 %

(a)Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.


11

Table of Contents
THE PENNANT GROUP, INC.
NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)
Three Months Ended June 30, 2019
Home Health and Hospice Services
Home Health ServicesHospice ServicesSenior Living ServicesTotal RevenueRevenue %
Medicare$11,990  $22,390  $  $34,380  41.6 %
Medicaid1,515  2,418  7,100  11,033  13.3  
Subtotal13,505  24,808  7,100  45,413  54.9  
Managed care6,829  370    7,199  8.7  
Private and other(a)
4,654  42  25,426  30,122  36.4  
Total revenue$24,988  $